Charles River Labs (CRL) PT Raised to $322 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $304.90 -1.89%
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 36
Rating Summary:
24 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 36
Join SI Premium – FREE
RBC Capital analyst Ryan Halsted raised the price target on Charles River Labs (NYSE: CRL) to $322.00 (from $282.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Stryker (SYK) PT Lowered to $310 at Truist Securities
- Charles River and Autolomous Partner to Transform Laboratory Execution Systems
- CrowdStrike (CRWD) PT Raised to $325 at StoneX Amid Accelerating AI Security Adoption
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
